Company Filing History:
Years Active: 2024
Title: Miguel Rodriguez Manotas: Innovator in Cancer Treatment
Introduction
Miguel Rodriguez Manotas is a notable inventor based in Torres de Cotillas, Spain. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.
Latest Patents
Rodriguez Manotas holds a patent for an "Anti-presenilin antibody for use in the prevention and/or treatment of cancer." This patent describes an antibody or fragment that targets presenilin, specifically the luminal loop of presenilin, to treat cancer. The invention involves administering a therapeutically effective quantity of the antibody or a pharmaceutical composition to individuals suffering from cancer.
Career Highlights
Throughout his career, Rodriguez Manotas has worked with various organizations, including Alzheimur 2012 S.L. and Fundación Universitaria San Antonio. His work has focused on developing innovative solutions to combat cancer, showcasing his dedication to improving patient outcomes.
Collaborations
Rodriguez Manotas has collaborated with notable colleagues such as Rogelio Gonzalez Sarmiento and Javier Fernandez Mateos. These partnerships have contributed to the advancement of his research and the development of effective cancer treatments.
Conclusion
Miguel Rodriguez Manotas is a pioneering inventor whose work in cancer treatment through innovative antibody development has the potential to make a significant impact in the medical field. His dedication to research and collaboration highlights the importance of innovation in addressing critical health challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.